Literature DB >> 11566041

Regulation of cyclo-oxygenase-2.

E Stack1, R N DuBois.   

Abstract

Over the past three decades studies have been conducted to determine the role of prostaglandins in normal physiology and in certain diseases. Cyclo-oxygenase (COX) or prostaglandin endoperoxide synthase (Pghs) is required for the conversion of arachidonic acid to prostaglandins. Two isoforms of this enzyme have been identified which are referred to as COX-1 and COX-2. Under most circumstances, COX-1 is produced constitutively, whereas COX-2 can be induced by several physiological stimuli and is expressed at sites of inflammation. Although these isozymes catalyze identical reactions, they are often regulated by different signalling systems. The goal of this chapter is to provide a review of the role of cyclo-oxygenase in biology and disease, and to summarize the current understanding of mechanisms for the regulation of COX-2 expression. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566041     DOI: 10.1053/bega.2001.0235

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  3 in total

1.  Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light.

Authors:  Hannah Serrage; Vladimir Heiskanen; William M Palin; Paul R Cooper; Michael R Milward; Mohammed Hadis; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2019-06-11       Impact factor: 3.982

2.  The role of PGE2 in intestinal inflammation and tumorigenesis.

Authors:  David C Montrose; Masako Nakanishi; Robert C Murphy; Simona Zarini; Jeremy P McAleer; Anthony T Vella; Daniel W Rosenberg
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-10-22       Impact factor: 3.072

3.  Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis.

Authors:  Derrick J Rossi; Antti Ylikorkala; Nina Korsisaari; Reijo Salovaara; Keijo Luukko; Virpi Launonen; Mark Henkemeyer; Ari Ristimaki; Lauri A Aaltonen; Tomi P Makela
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.